Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study-Reference-Cited by-同舟云学术

Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study

Published:2023-01 Issue:1 Volume:23 Page:40-48
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Casulo Carla,Herold Michael,Hiddemann Wolfgang,Iyengar Sunil,Marcus Robert E.,Seymour John F.^ORCID,Launonen Aino,Knapp Andrea,Nielsen Tina G.,Mir Farheen

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Controversies in the treatment of follicular lymphoma;Hübel;Hemasphere,2020

2. Can histologic transformation of follicular lymphoma be predicted and prevented?;Kridel;Blood,2017

3. Follicular lymphoma: 2018 update on diagnosis and management;Freedman;Am J Hematol,2018

4. Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression;Seymour;Haematologica,2019

5. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma;Maurer;Am J Hematol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up of Patients With Follicular Lymphoma Using Next Generation Sequencing to Detect Minimal Residual Disease;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. How Should We Risk Stratify and Tailor Therapy for Relapsed/Refractory Indolent Lymphoma?;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation;Frontiers in Immunology;2023-12-08

4. DLBCL arising from indolent lymphomas: How are they different?;Seminars in Hematology;2023-11

5. Personalised therapy in follicular lymphoma – is the dial turning?;Hematological Oncology;2023-07-22